Medication info
Astra Setsemi Tablet

Astra Setsemi Tablet

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›18.75mg / 1 tabletAcetaminophen›162.5mg / 1 tablet
Manufacturer / importer
Selbion Co., Ltd.
Appearance
Pale yellow rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201905262 · Approved 2019.07.24 · Insurance code 055800250

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Older adults Administer the usual adult dose. However, since the elimination half-life of tramadol increases by 17% when tramadol is administered orally to older adults aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment In patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, it is not necessary to readminister this medicine after dialysis to maintain analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: Adjust the dose according to the severity of the patient's pain and response to treatment. An initial dose of 4 tablets is recommended; thereafter, allow an interval of at least 6 hours between doses and do not exceed 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the condition, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
Selbion Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Older adults Administer the usual adult dose. However, since the elimination half-life of tramadol increases by 17% when tramadol is administered orally to older adults aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment In patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, it is not necessary to readminister this medicine after dialysis to maintain analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: Adjust the dose according to the severity of the patient's pain and response to treatment. An initial dose of 4 tablets is recommended; thereafter, allow an interval of at least 6 hours between doses and do not exceed 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the condition, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Precautions

This medication may place a burden on the liver, so those who drink more than three glasses of alcohol daily should consult a doctor or pharmacist before use. This medication can rarely cause severe skin reactions, so if skin rashes or hypersensitivity occur, discontinue use immediately and consult healthcare personnel. One of the ingredients in this medication may increase the risk of seizures, so caution is necessary for those with a history of seizures or those taking certain antidepressants and other medications. Rarely, this medication can lead to severe allergic reactions, so if there is difficulty breathing or severe skin reactions, inform healthcare personnel immediately. This medication may suppress respiration in patients with severe respiratory conditions, so it should be administered in a setting equipped with special equipment. Taking this medication with alcohol or CNS depressants such as sedatives can cause severe drowsiness or respiratory depression, so extreme caution is advised when combining. Patients with head injuries or elevated intracranial pressure should be cautious as this medication may increase brain pressure due to respiratory depression. This medication can cause physical and psychological dependence, so long-term use should be monitored for signs of dependence. Patients with impaired liver function or liver disease should consult a doctor before use, as there is a heightened risk of hepatotoxicity. Patients with certain genetic traits may experience accelerated metabolism of this medication, increasing the risk of respiratory depression and other hazards; in such cases, dosage adjustment or alternative medications should be considered. Children under 12 years and some postoperative pediatric patients should not use this medication, and adolescents aged 12 to 18 should avoid use if there are special risk factors. This medication may cause sleep apnea or hypoxia, so symptoms should be continuously monitored, and dosage adjusted or discontinued if necessary. Elderly patients or those at risk of hyponatremia should be closely monitored for the occurrence of hyponatremia during use of this medication. This medication may interact with certain drugs, so if taking other medications, consult a doctor or pharmacist, particularly when combining with MAO inhibitors, antidepressants, antibiotics, or warfarin. Pregnant or breastfeeding women should consult a doctor before use, and nursing mothers may need to stop breastfeeding or need special monitoring while using this medication. This medication can cause drowsiness or dizziness, so caution is necessary when driving or operating machinery. Overdose can result in severe respiratory depression, seizures, liver damage, etc., so adhere to the prescribed dosage, and seek emergency help immediately in case of overdose. This medication should be stored out of the reach of children and managed carefully to prevent misuse.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reaction, respiratory depression, deep sedation, coma, death, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disorders, disorientation, spatial disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory loss, tremor, paresthesia, attentional disorder, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, visual blurring, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, elevated liver enzymes, generalized pruritus, cold sweat, urinary dysfunction, erectile dysfunction, asthenia, chest pain, abnormal emotions, chills, chest discomfort, malaise, drug withdrawal syndrome, thirst, irritability, feeling of warmth, weight loss, increased serum creatinine, anaphylactic reaction, affecting unstable emotions, delirium, suicidal ideation, muscle hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, hyponatremia, fixed rash, asthenia, fever, edema, stiffness, syncope, congestive heart failure, vertigo, confusion, exacerbation of migraine, involuntary muscle contractions, exertional dyspnea, cough, bronchitis, urinary retention, frequency of urination, abnormal kidney function tests, oliguria, increased sweating, dysphagia, tongue swelling, increased saliva, progression of rectal cancer, progression of esophageal cancer, progression of stomach cancer, paralytic ileus, hiccups, cholecystitis, insomnia, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, thrombocytopenia, palpitations, arrhythmia, exacerbation of hypertension, aortic stenosis, hematochezia, increased cholesterol, tinnitus, hip pain, thigh pain, allergic rhinitis, epistaxis, abnormal visual fields, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function, nausea, vomiting, dyspepsia, abdominal pain, constipation, dry mouth, diarrhea, dysphagia, flatulence, tongue swelling, increased saliva, progression of rectal cancer, progression of esophageal cancer, progression of stomach cancer, paralytic ileus, hiccups, cholecystitis, asthenia, fever, edema, stiffness, syncope, congestive heart failure, vertigo, confusion, exacerbation of migraine, involuntary muscle contractions, exertional dyspnea, cough, bronchitis, urinary retention, frequency of urination, abnormal kidney function tests, oliguria, increased sweating, dysphagia, tongue swelling, increased saliva, progression of rectal cancer, progression of esophageal cancer, progression of stomach cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, anxiety, nervousness, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, thrombocytopenia, palpitations, arrhythmia, exacerbation of hypertension, aortic stenosis, hematochezia, increased cholesterol, weight loss, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, epistaxis, abnormal visual fields, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure and kept at room temperature between 1 to 30 degrees Celsius. Storing it this way can help maintain the medication's effectiveness for a long time.

Appearance and packaging

Appearance

Pale yellow rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.